These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16540757)

  • 41. [Tuberous sclerosis].
    Yamashita Y; Hino O
    Nihon Rinsho; 2000 Jul; 58(7):1455-9. PubMed ID: 10921323
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex.
    Nellist M; Verhaaf B; Goedbloed MA; Reuser AJ; van den Ouweland AM; Halley DJ
    Hum Mol Genet; 2001 Dec; 10(25):2889-98. PubMed ID: 11741832
    [TBL] [Abstract][Full Text] [Related]  

  • 43. mTORC1-mediated inhibition of polycystin-1 expression drives renal cyst formation in tuberous sclerosis complex.
    Pema M; Drusian L; Chiaravalli M; Castelli M; Yao Q; Ricciardi S; Somlo S; Qian F; Biffo S; Boletta A
    Nat Commun; 2016 Mar; 7():10786. PubMed ID: 26931735
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tuberous sclerosis complex renal disease.
    Dixon BP; Hulbert JC; Bissler JJ
    Nephron Exp Nephrol; 2011; 118(1):e15-20. PubMed ID: 21071977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non-penetrance in tuberous sclerosis.
    Osborne JP; Jones AC; Burley MW; Jeganathan D; Young J; O'Callaghan FJ; Sampson JR; Povey S
    Lancet; 2000 May; 355(9216):1698. PubMed ID: 10905251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reply to Yang Zhao, Wenda Wang, and Yushi Zhang's Letter to the Editor re: Sounak Gupta, Christine M. Lohse, Ross Rowsey, et al. Renal Neoplasia in Polycystic Kidney Disease: An Assessment of Tuberous Sclerosis Complex-associated Renal Neoplasia and PKD1/TSC2 Contiguous Gene Deletion Syndrome. Eur Urol 2022;81:229-33.
    Gupta S; Lohse CM; Jimenez RE; Cheville JC
    Eur Urol; 2022 Oct; 82(4):e117. PubMed ID: 35810047
    [No Abstract]   [Full Text] [Related]  

  • 47. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients.
    Green AJ; Smith M; Yates JR
    Nat Genet; 1994 Feb; 6(2):193-6. PubMed ID: 8162074
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [TSC2/PKD1 contiguous gene syndrome. Report of two cases].
    Yadaden T; Molinié V; Ples R; Lazure T; Benoît G; Yonneau L; Ferlicot S
    Ann Pathol; 2007 Apr; 27(2):136-40. PubMed ID: 17909474
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Linking tuberous sclerosis complex, excessive mTOR signaling, and age-related neurodegeneration: a new association between TSC1 mutation and frontotemporal dementia.
    Olney NT; Alquezar C; Ramos EM; Nana AL; Fong JC; Karydas AM; Taylor JB; Stephens ML; Argouarch AR; Van Berlo VA; Dokuru DR; Sherr EH; Jicha GA; Dillon WP; Desikan RS; De May M; Seeley WW; Coppola G; Miller BL; Kao AW
    Acta Neuropathol; 2017 Nov; 134(5):813-816. PubMed ID: 28828560
    [No Abstract]   [Full Text] [Related]  

  • 50. TSC1 and TSC2: genes that are mutated in the human genetic disorder tuberous sclerosis.
    Sampson JR
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):592-6. PubMed ID: 12773162
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tuberous sclerosis: from tubers to mTOR.
    Kwiatkowski DJ
    Ann Hum Genet; 2003 Jan; 67(Pt 1):87-96. PubMed ID: 12556239
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A mutation screen of the TSC1 gene reveals 26 protein truncating mutations and 1 splice site mutation in a panel of 79 tuberous sclerosis patients.
    Young JM; Burley MW; Jeremiah SJ; Jeganathan D; Ekong R; Osborne JP; Povey S
    Ann Hum Genet; 1998 May; 62(Pt 3):203-13. PubMed ID: 9803264
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tuberous sclerosis.
    Roach ES; Delgado MR
    Dermatol Clin; 1995 Jan; 13(1):151-61. PubMed ID: 7712641
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genotype-phenotype correlations in tuberous sclerosis: who and how to treat.
    Goh S; Weiss WA
    Ann Neurol; 2006 Nov; 60(5):505-507. PubMed ID: 17120247
    [No Abstract]   [Full Text] [Related]  

  • 55. Missense mutations to the TSC1 gene cause tuberous sclerosis complex.
    Nellist M; van den Heuvel D; Schluep D; Exalto C; Goedbloed M; Maat-Kievit A; van Essen T; van Spaendonck-Zwarts K; Jansen F; Helderman P; Bartalini G; Vierimaa O; Penttinen M; van den Ende J; van den Ouweland A; Halley D
    Eur J Hum Genet; 2009 Mar; 17(3):319-28. PubMed ID: 18830229
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence for genetic heterogeneity in tuberous sclerosis: one locus on chromosome 9 and at least one locus elsewhere.
    Northrup H; Kwiatkowski DJ; Roach ES; Dobyns WB; Lewis RA; Herman GE; Rodriguez E; Daiger SP; Blanton SH
    Am J Hum Genet; 1992 Oct; 51(4):709-20. PubMed ID: 1415216
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The genetic basis of tuberous sclerosis.
    Young J; Povey S
    Mol Med Today; 1998 Jul; 4(7):313-9. PubMed ID: 9743993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis.
    Kerfoot C; Wienecke R; Menchine M; Emelin J; Maize JC; Welsh CT; Norman MG; DeClue JE; Vinters HV
    Brain Pathol; 1996 Oct; 6(4):367-75. PubMed ID: 8944308
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Similarity of balloon cells in focal cortical dysplasia to giant cells in tuberous sclerosis.
    Jozwiak J; Kotulska K; Jozwiak S
    Epilepsia; 2006 Apr; 47(4):805. PubMed ID: 16650151
    [No Abstract]   [Full Text] [Related]  

  • 60. Tuberous sclerosis complex.
    DiMario FJ; Sahin M; Ebrahimi-Fakhari D
    Pediatr Clin North Am; 2015 Jun; 62(3):633-48. PubMed ID: 26022167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.